Skip to main content

IG 302 Pill - white round, 9mm

Pill with imprint IG 302 is White, Round and has been identified as Alfuzosin Hydrochloride Extended-Release 10 mg. It is supplied by Cipla USA, Inc.

Alfuzosin is used in the treatment of Benign Prostatic Hyperplasia and belongs to the drug class alpha blockers. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IG 302

Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302 Front
Alfuzosin hydrochloride extended-release 10 mg IG 302 Back
Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302

Alfuzosin Hydrochloride Extended-Release

Imprint
IG 302
Strength
10 mg
Color
White
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Alpha blockers
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc.
Manufacturer
InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC)
69097-0844
Inactive Ingredients
microcrystalline cellulose, guar gum, hypromelloses, silicon dioxide, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.